Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. Goodman SG, Steg PG, Szarek M, Bhatt DL, et al. J Am Coll Cardiol 2020;75:448-451.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goodman SG, Steg PG, Szarek M, Bhatt DL, et al. Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. J Am Coll Cardiol 2020;75:448-451.
PMID: 32000957